COVID-19 is still raging, traders are starting to bet on “hornworms around the election,” and the US and China could not even agree on planning a scheduled meeting over the weekend. None of this is, of course, significant to the stock market. Goldman Sachs became the latest company to increase …
Read More »
The S&P 500 index is crawling to the brink of a rare barrage, and persistent uncertainties created by the COVID-19 pandemic in its rise. Although the most important benchmark of the stock in the world is likely to have climbed to a record, the rally has been postponed by the …
Read More »
(Photo by Joe Raedle / Getty Images) Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • President Donald Trump said Friday that McKesson would work with the U.S. government to spread a coronavirus vaccine if one is approved. …
Read More »
The stock market may fall if a COVID-19 vaccine receives formal FDA approval. I know I’m advancing myself because it does not guarantee that an effective vaccine will ever be produced. But with eight faxes now in Phase III studies, and with Russia claiming bragging rights by being the first …
Read More »
The UK government said on Friday it had signed deals for a further 90 million doses of coronavirus vaccines as the country raced to secure supplies of experimental shots to combat the pandemic. Under the new agreements in principle, the American medicine developer Novavax NVAX, + 7.12% will supply 60 …
Read More »